✦ LIBER ✦

24-hour non-invasive blood pressure monitoring of felodipine-metoprolol extende release tablet

✍ Scribed by RABBIA, F

Book ID: 116156820
Publisher: Nature Publishing Group
Year: 1996
Tongue: English
Weight: 291 KB
Volume: 9
Category: Article
ISSN: 0895-7061
DOI: 10.1016/0895-7061(96)81967-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

E110 More effective blood pressure contr

E110 More effective blood pressure control with felodipine-metoprolol combination than with amlodipine. 24-hour ambulatory blood pressure monitoring

✍ E. Zannad 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 129 KB

Effect of Amlodipine Versus Felodipine E

Effect of Amlodipine Versus Felodipine Extended Release on 24-Hour Ambulatory Blood Pressure in Hypertension

✍ Jan Östergren; Hans Isaksson; Ulf Brodin; Åke Schwan; K.Peter Öhman 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 193 KB

REPRODUCIBILITY OF 24-HOUR NON-INVASIVE

REPRODUCIBILITY OF 24-HOUR NON-INVASIVE AMBULATORY BLOOD PRESSURE MONITORING USING THE SUNTECH ACCUTRACKER

✍ L. B. Torre; I. L. Rouse; L. J. Beilin 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 252 KB

Non-invasive 24-hr monitoring of high bl

Non-invasive 24-hr monitoring of high blood pressure in climacteric outpatients

✍ Villecco, A.S.; de Aloysio, D.; Pilati, G.; Mauloni, M.; Roncuzzi, A.; Bottiglio 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 486 KB

Comparison of the antihypertensive effic

Comparison of the antihypertensive efficiency of nitrendipine, metoprolol, mepindolol and enalapril using ambulatory 24-hour blood pressure monitoring

✍ Joachim Schrader; Gerhard Schoel; Heike Buhr-Schinner; Michael Kandt; Gerhard Wa 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 731 KB

Antihypertensive efficacy of twice daily

Antihypertensive efficacy of twice daily controlled release diltiazem using 24 hour intra-arterial blood pressure monitoring

✍ B. S. Sridhara; P. Thomas; A. Lahiri; E. B. Raftery 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 434 KB

The aim of the study was to examine the efficacy of a new controlled release formulation of diltiazem administered in a twice-daily dose in patients with essential hypertension using 24 hour intra-arterial ambulatory blood pressure monitoring. Sixteen patients (2 female) of mean age 53 years with m